Blog – Plano Peptides (ARL)

News

Retatrutide vs. Aleniglipron: Oral GLP-1 Efficacy and Dosing Considerations for 2026

August 28, 2026|Caleb Cross

Retatrutide and aleniglipron are two oral GLP-1 candidates for 2026. We compare their efficacy, dosing, safety, and patient fit to help you understand the

Retatrutide Gallbladder Safety: New Imaging Data

August 26, 2026|Caleb Cross

New imaging data on retatrutide's glucagon receptor agonism raises questions about gallbladder safety in high-risk patients. This Q&A covers what the

Semaglutide and Depression: No Clear Link Found

August 21, 2026|Caleb Cross

Semaglutide and depression: no clear link found in research. Learn what the evidence says, how retatrutide compares, and what prescribers should

Your cart is empty

News

Retatrutide vs. Aleniglipron: Oral GLP-1 Efficacy and Dosing Considerations for 2026

Retatrutide vs. Aleniglipron: Oral GLP-1 Efficacy and Dosing Considerations for 2026